Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Influenza, Human"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 10250
Tytuł:
Epidemiological changes of acute respiratory infections in children: A single-center experience after COVID-19 lockdown.
Autorzy:
Stacevičienė I; Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Ivaškevičienė I; Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Burokienė S; Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Steponavičienė A; Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Vaičiūnienė D; Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Tarutytė G; Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Jankauskienė A; Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 05; Vol. 19 (4), pp. e0300877. Date of Electronic Publication: 2024 Apr 05 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/complications
COVID-19*/epidemiology
COVID-19*/complications
Respiratory Tract Infections*
Respiratory Syncytial Virus Infections*/epidemiology
Respiratory Syncytial Virus, Human*
Humans ; Child ; Adolescent ; Retrospective Studies ; Cross-Sectional Studies ; Pandemics ; Communicable Disease Control ; Hospitalization ; Seasons
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
County-Level Factors Associated With Influenza and COVID-19 Vaccination in Indiana, 2020‒2022.
Autorzy:
Kasting ML; Monica L. Kasting, Alfu Laily, and Laura M. Schwab-Reese are with the Department of Public Health at Purdue University, West Lafayette, IN. Heather N. Burney and Joanne K. Daggy are with the Department of Biostatistics and Health Data Science at the Indiana University School of Medicine, Indianapolis. Katharine J. Head is with the Department of Communication Studies at Indiana University‒Purdue University, Indianapolis. Gregory D. Zimet is professor emeritus of Pediatrics and Psychiatry at the Indiana University School of Medicine, Indianapolis.
Laily A; Monica L. Kasting, Alfu Laily, and Laura M. Schwab-Reese are with the Department of Public Health at Purdue University, West Lafayette, IN. Heather N. Burney and Joanne K. Daggy are with the Department of Biostatistics and Health Data Science at the Indiana University School of Medicine, Indianapolis. Katharine J. Head is with the Department of Communication Studies at Indiana University‒Purdue University, Indianapolis. Gregory D. Zimet is professor emeritus of Pediatrics and Psychiatry at the Indiana University School of Medicine, Indianapolis.
Burney HN; Monica L. Kasting, Alfu Laily, and Laura M. Schwab-Reese are with the Department of Public Health at Purdue University, West Lafayette, IN. Heather N. Burney and Joanne K. Daggy are with the Department of Biostatistics and Health Data Science at the Indiana University School of Medicine, Indianapolis. Katharine J. Head is with the Department of Communication Studies at Indiana University‒Purdue University, Indianapolis. Gregory D. Zimet is professor emeritus of Pediatrics and Psychiatry at the Indiana University School of Medicine, Indianapolis.
Head KJ; Monica L. Kasting, Alfu Laily, and Laura M. Schwab-Reese are with the Department of Public Health at Purdue University, West Lafayette, IN. Heather N. Burney and Joanne K. Daggy are with the Department of Biostatistics and Health Data Science at the Indiana University School of Medicine, Indianapolis. Katharine J. Head is with the Department of Communication Studies at Indiana University‒Purdue University, Indianapolis. Gregory D. Zimet is professor emeritus of Pediatrics and Psychiatry at the Indiana University School of Medicine, Indianapolis.
Daggy JK; Monica L. Kasting, Alfu Laily, and Laura M. Schwab-Reese are with the Department of Public Health at Purdue University, West Lafayette, IN. Heather N. Burney and Joanne K. Daggy are with the Department of Biostatistics and Health Data Science at the Indiana University School of Medicine, Indianapolis. Katharine J. Head is with the Department of Communication Studies at Indiana University‒Purdue University, Indianapolis. Gregory D. Zimet is professor emeritus of Pediatrics and Psychiatry at the Indiana University School of Medicine, Indianapolis.
Zimet GD; Monica L. Kasting, Alfu Laily, and Laura M. Schwab-Reese are with the Department of Public Health at Purdue University, West Lafayette, IN. Heather N. Burney and Joanne K. Daggy are with the Department of Biostatistics and Health Data Science at the Indiana University School of Medicine, Indianapolis. Katharine J. Head is with the Department of Communication Studies at Indiana University‒Purdue University, Indianapolis. Gregory D. Zimet is professor emeritus of Pediatrics and Psychiatry at the Indiana University School of Medicine, Indianapolis.
Schwab-Reese LM; Monica L. Kasting, Alfu Laily, and Laura M. Schwab-Reese are with the Department of Public Health at Purdue University, West Lafayette, IN. Heather N. Burney and Joanne K. Daggy are with the Department of Biostatistics and Health Data Science at the Indiana University School of Medicine, Indianapolis. Katharine J. Head is with the Department of Communication Studies at Indiana University‒Purdue University, Indianapolis. Gregory D. Zimet is professor emeritus of Pediatrics and Psychiatry at the Indiana University School of Medicine, Indianapolis.
Pokaż więcej
Źródło:
American journal of public health [Am J Public Health] 2024 Apr; Vol. 114 (4), pp. 415-423. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
COVID-19*/epidemiology
COVID-19*/prevention & control
Influenza Vaccines*/therapeutic use
Aged ; Adult ; Humans ; Female ; United States/epidemiology ; COVID-19 Vaccines ; Indiana/epidemiology ; Medicare ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Influenza vaccine coverage and factors associated with non-vaccination among caregiving and care-receiving adults in the Canadian Longitudinal Study on Aging (CLSA).
Autorzy:
Gravagna K; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. .
Wolfson C; Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, QC, Canada.; Neuroepidemiology Research Unit, Research Institute of the McGill University Health Centre, Montreal General Hospital, Montreal, QC, Canada.
Basta NE; Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, QC, Canada.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Mar 29; Vol. 24 (1), pp. 924. Date of Electronic Publication: 2024 Mar 29.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*
Influenza, Human*/prevention & control
Influenza, Human*/epidemiology
Adult ; Humans ; Longitudinal Studies ; Cross-Sectional Studies ; Canada/epidemiology ; Vaccination ; Aging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cross-sectional study of influenza trends and costs in Malaysia between 2016 and 2018.
Autorzy:
Wan Puteh SE; Department of Community Health, Pusat Perubatan Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Aazmi MS; School of Biology, Faculty of Applied Sciences, Universiti Teknologi MARA, Shah Alam, Selangor, Malaysia.
Aziz MN; Lablink (M) Sdn. Bhd, Kuala Lumpur, Malaysia.
Kamarudin N'; Department of Community Health, Pusat Perubatan Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Sam JI; Department of Medical Microbiology, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia.
Thayan R; Infectious Disease Research Centre, Institute for Medical Research, Ministry of Health Malaysia, Putrajaya, Malaysia.
Wan Mahiyuddin WR; Environmental Health Research Centre, Institute for Medical Research, Ministry of Health Malaysia, Putrajaya, Malaysia.
Wan Mohamed Noor WN; Disease Control Division, Ministry of Health Malaysia, Putrajaya, Malaysia.
Cheong A; Medical Department, Sanofi, Petaling Jaya, Malaysia.
El Guerche-Séblain C; Global Vaccine Epidemiology and Modelling Department, Sanofi, Singapore, Singapore.
Khor J; Medical Department, Sanofi, Petaling Jaya, Malaysia.
Zamri EN; Infectious Disease Research Centre, Institute for Medical Research, Ministry of Health Malaysia, Putrajaya, Malaysia.
Lam JY; Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
Sekawi Z; Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 22; Vol. 19 (3), pp. e0301068. Date of Electronic Publication: 2024 Mar 22 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Virus Diseases*
Humans ; Infant ; Cross-Sectional Studies ; Retrospective Studies ; Malaysia/epidemiology ; Sentinel Surveillance ; Seasons
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Insights from Avian Influenza: A Review of Its Multifaceted Nature and Future Pandemic Preparedness.
Autorzy:
He J; Division of Natural and Applied Science, Duke Kunshan University, No. 8 Duke Avenue, Kunshan 215316, China.
Kam YW; Division of Natural and Applied Science, Duke Kunshan University, No. 8 Duke Avenue, Kunshan 215316, China.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Mar 17; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 17.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Influenza in Birds*/epidemiology
Influenza in Birds*/prevention & control
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*
Influenza A virus*/genetics
Animals ; Humans ; Pandemic Preparedness ; Pandemics/prevention & control
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
COVID-19 and flu vaccination in Romania, post pandemic lessons in healthcare workers and general population.
Autorzy:
Malița MA; Department of Dental Technology, Faculty of Midwifery and Nursing, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
Manolescu LSC; Department of Microbiology, Parasitology and Virology, Faculty of Midwifery and Nursing, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
Perieanu VȘ; Department of Dental Technology, Faculty of Midwifery and Nursing, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
Babiuc I; Department of Dental Technology, Faculty of Midwifery and Nursing, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
Marcov EC; Department of Restorative Dentistry, Faculty of Dentistry, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
Ionescu C; Department of Dental Prostheses, Faculty of Dentistry, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
Beuran IA; Department of Dental Technology, Faculty of Midwifery and Nursing, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
Prasacu I; Department of Fundamental Sciences, Faculty of Pharmacy, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
Perieanu MV; Department of Restorative Dentistry, Faculty of Dentistry, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
Voinescu I; Department of Dental Technology, Faculty of Midwifery and Nursing, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
Radu MC; Department of Microbiology, Parasitology and Virology, Faculty of Midwifery and Nursing, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
Burlibasa L; Department of Genetics, Faculty of Biology, University of Bucharest, Bucharest, Romania.
Dumitrescu AI; Department of Fundamental Sciences, Faculty of Pharmacy, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
Burlibasa M; Department of Dental Technology, Faculty of Midwifery and Nursing, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 07; Vol. 19 (3), pp. e0299568. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Adolescent ; Adult ; Humans ; Middle Aged ; Young Adult ; COVID-19 Vaccines ; Cross-Sectional Studies ; Health Personnel ; Pandemics/prevention & control ; Romania/epidemiology ; Vaccination ; Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The weekly P25 of the age of the influenza-like illness shows a higher correlation with COVID-19 mortality than rapid tests and could predict the evolution of COVID-19 pandemics in sentinel surveillance, Piura, Perú, 2021.
Autorzy:
Ocaña Gutiérrez VR; School of Medicine, Cesar Vallejo University, Piura, Perú.
González Ramírez RA; School of Medicine, Cesar Vallejo University, Piura, Perú.; Department of Public Health, School of Medicine, National University of Cajamarca, Cajamarca, Perú.
Ocaña Aguilar VA; School of Medicine, Cesar Vallejo University, Piura, Perú.; Department of Public Health, School of Medicine, National University of Cajamarca, Cajamarca, Perú.
Ocaña Aguilar NG; Department of Public Health, School of Medicine, National University of Cajamarca, Cajamarca, Perú.
Holguín Mauricci CE; Department of Public Health, School of Medicine, National University of Piura, Piura, Perú.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 07; Vol. 19 (3), pp. e0295309. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/diagnosis
Influenza, Human*/epidemiology
COVID-19*/diagnosis
COVID-19*/epidemiology
Adult ; Humans ; Aged ; Sentinel Surveillance ; Pandemics ; Peru ; Seasons
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Antigenic drift and immunity gap explain reduction in protective responses against influenza A(H1N1)pdm09 and A(H3N2) viruses during the COVID-19 pandemic: a cross-sectional study of human sera collected in 2019, 2021, 2022, and 2023.
Autorzy:
Fossum E; Division of Infection Control, Department of Virology, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway. .
Rohringer A; Division of Infection Control, Department of Virology, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway.
Aune T; Division of Infection Control, Department of Virology, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway.
Rydland KM; Division of Infection Control, Department of Vaccines, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway.
Bragstad K; Division of Infection Control, Department of Virology, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway.
Hungnes O; Division of Infection Control, Department of Virology, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway.
Pokaż więcej
Źródło:
Virology journal [Virol J] 2024 Mar 06; Vol. 21 (1), pp. 57. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza A Virus, H1N1 Subtype*
COVID-19*/epidemiology
Child ; Humans ; Cross-Sectional Studies ; Antigenic Drift and Shift ; Influenza A Virus, H3N2 Subtype ; Pandemics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines.
Autorzy:
Lim CML; Infection and Immunity Research Strength, Jeffrey Cheah School of Medicine & Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia.
Komarasamy TV; Infection and Immunity Research Strength, Jeffrey Cheah School of Medicine & Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia.
Adnan NAAB; Infection and Immunity Research Strength, Jeffrey Cheah School of Medicine & Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia.
Radhakrishnan AK; Infection and Immunity Research Strength, Jeffrey Cheah School of Medicine & Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia.
Balasubramaniam VRMT; Infection and Immunity Research Strength, Jeffrey Cheah School of Medicine & Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Mar; Vol. 18 (3), pp. e13276.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Orthomyxoviridae*
Orthomyxoviridae Infections*
Humans ; Antibodies, Viral ; Hemagglutinins ; Viral Proteins ; Hemagglutinin Glycoproteins, Influenza Virus/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Interim Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza - California, October 2023-January 2024.
Autorzy:
Zhu S
Quint J
León TM
Sun M
Li NJ
Tenforde MW
Jain S
Schechter R
Hoover C
Murray EL
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2024 Feb 29; Vol. 73 (8), pp. 175-179. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Adolescent ; Adult ; Child ; Infant ; Humans ; Vaccine Efficacy ; Vaccination ; California/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Association between Statins Administration and Influenza Susceptibility: A Systematic Review and Meta-Analysis of Longitudinal Studies.
Autorzy:
Wu F; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Wang C; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Li S; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Ye Y; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Cui M; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Liu Y; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Jiang S; Nanshan District Center for Disease Control and Prevention, Shenzhen 518000, China.
Qian J; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Yuan J; Nanshan District Center for Disease Control and Prevention, Shenzhen 518000, China.
Shu Y; NHC Key Laboratory of System Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100730, China.
Sun C; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.; Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou 514400, China.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Feb 10; Vol. 16 (2). Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Aged ; Female ; Humans ; Middle Aged ; Longitudinal Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus-associated disease in breakthrough infections in adults ≥60 years of age.
Autorzy:
Curran D; GSK Wavre Belgium.
Matthews S; Freelance c/o GSK Wavre Belgium.
Cabrera ES; GSK Wavre Belgium.
Pérez SN; CAP Centelles Barcelona Spain.
Breva LP; Vaccine Research FISABIO-Public Health Valencia Spain.
Rämet M; Finnish Vaccine Research Tampere Finland.
Helman L; Department of Clinical Medicine George Washington University School of Medicine & Health Sciences Washington District of Columbia USA.
Park DW; Korea University Ansan Hospital Ansan Republic of Korea.
Schwarz TF; Institute of Laboratory Medicine and Vaccination Centre Klinikum Würzburg Mitte Würzburg Germany.
Melendez IMG; Hospital Universitario Fundacion Alcorcon Madrid Spain.
Schaefer A; Medizentrum Essen Borbeck Essen Germany.
Roy N; Medicor Research Greater Sudbury Canada.
Stephan B; SGS proDERM Schenefeld Germany.
Molnar D; GSK Wavre Belgium.
Kostanyan L; GSK Wavre Belgium.
Powers JH 3rd; Department of Clinical Medicine George Washington University School of Medicine & Health Sciences Washington District of Columbia USA.
Hulstrøm V; GSK Wavre Belgium.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Feb 03; Vol. 18 (2), pp. e13236. Date of Electronic Publication: 2024 Feb 03 (Print Publication: 2024).
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Respiratory Syncytial Virus Vaccines*/therapeutic use
Respiratory Syncytial Virus Infections*/epidemiology
Respiratory Syncytial Virus Infections*/prevention & control
Respiratory Syncytial Virus, Human*
Respiratory Tract Infections*
Influenza, Human*/prevention & control
Influenza, Human*/drug therapy
Humans ; Aged ; Middle Aged ; Breakthrough Infections ; Viral Fusion Proteins ; Antibodies, Viral ; Antibodies, Neutralizing
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Frequency of Asthma Exacerbations and Upper Respiratory Tract Infections Among Adults With Asthma According to Vaccination Status: Does the annual influenza vaccine have a protective effect?
Autorzy:
Kharusi ZA; Family Medicine, Directorate-General of Primary Healthcare, Ministry of Health, Muscat, Oman.
Kalbani RA; Family Medicine, Directorate-General of Primary Healthcare, Ministry of Health, Muscat, Oman.
Al-Hadhrami R; Department of Family Medicine & Public Health, Sultan Qaboos University Hospital, Sultan Qaboos University, Muscat, Oman.
Pokaż więcej
Źródło:
Sultan Qaboos University medical journal [Sultan Qaboos Univ Med J] 2024 Feb; Vol. 24 (1), pp. 70-75. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*
Influenza, Human*/complications
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Respiratory Tract Infections*/epidemiology
Respiratory Tract Infections*/prevention & control
Asthma*/complications
Asthma*/epidemiology
Adult ; Humans ; Female ; Male ; Retrospective Studies ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
Autorzy:
Rose AMC; Epiconcept, Paris, France.
Pozo F; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Martínez-Baz I; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.
Mazagatos C; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.
Bossuyt N; Sciensano, Brussels, Belgium.
Cauchi JP; Department for Health Regulation, Health Promotion and Disease Prevention, Msida, Malta.
Petrović G; Croatian Institute of Public Health, Zagreb, Croatia.
Loghin II; St Parascheva Clinical Hospital of Infectious Diseases, Iasi, Romania.
Vaikutyte R; Lithuanian University of Health Sciences, Kaunas, Lithuania.
Buda S; Robert Koch Institute, Berlin, Germany.
Machado A; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
Duffy R; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Oroszi B; Semmelweis University, Budapest, Hungary.
Howard J; Epiconcept, Paris, France.
Echeverria A; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.
Andreu C; Subdirección de Epidemiología, Dirección General de Salud Pública, Servicio Extremeño de Salud, Mérida, Spain.
Barbezange C; Sciensano, Brussels, Belgium.
Džiugytė A; Department for Health Regulation, Health Promotion and Disease Prevention, Msida, Malta.
Nonković D; Teaching Public Health Institute of Split-Dalmatia County, Split, Croatia.
Popescu CP; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania.
Majauskaite F; Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania.
Tolksdorf K; Robert Koch Institute, Berlin, Germany.
Gomez V; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
Domegan L; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Horváth JK; Semmelweis University, Budapest, Hungary.
Castilla J; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.
García M; Dirección General de Salud Pública, Departamento de Sanidad, Gobierno de Aragón, Zaragoza, Spain.
Demuyser T; Department of Microbiology and Infection control, UZ Brussel, Brussels, Belgium.
Borg ML; Department for Health Regulation, Health Promotion and Disease Prevention, Msida, Malta.
Tabain I; Croatian Institute of Public Health, Zagreb, Croatia.
Lazar M; 'Cantacuzino' National Military-Medical Institute for Research and Development, Bucharest, Romania.
Kubiliute I; Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania.
Dürrwald R; Robert Koch Institute, Berlin, Germany.
Guiomar R; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Kristóf K; Semmelweis University, Budapest, Hungary.
Nicolay N; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Bacci S; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Kissling E; Epiconcept, Paris, France.
Pokaż więcej
Corporate Authors:
VEBIS SARI VE network team
Belgium SARI Surveillance Network (BelsariNet)
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Feb; Vol. 18 (2), pp. e13255.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza A Virus, H1N1 Subtype*/genetics
Influenza Vaccines*
Pneumonia*
Adult ; Humans ; Seasons ; Influenza A Virus, H3N2 Subtype/genetics ; Case-Control Studies ; Vaccine Efficacy ; Europe/epidemiology ; Hospitalization ; Hospitals ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of the COVID-19 related border restrictions on influenza and other common respiratory viral infections in New Zealand.
Autorzy:
Huang QS; Institute of Environmental Science and Research, Wellington, New Zealand.
Turner N; University of Auckland, Auckland, New Zealand.
Wood T; Institute of Environmental Science and Research, Wellington, New Zealand.
Anglemyer A; Institute of Environmental Science and Research, Wellington, New Zealand.; University of Otago, Dunedin, New Zealand.
McIntyre P; University of Otago, Dunedin, New Zealand.
Aminisani N; Institute of Environmental Science and Research, Wellington, New Zealand.
Dowell T; University of Otago, Dunedin, New Zealand.
Trenholme A; Te Whatu Ora, Health New Zealand Counties Manukau, Auckland, New Zealand.
Byrnes C; Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand.
Balm M; Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
McIntosh C; Te Whatu Ora, Health New Zealand Counties Manukau, Auckland, New Zealand.
Jefferies S; Institute of Environmental Science and Research, Wellington, New Zealand.
Grant CC; University of Auckland, Auckland, New Zealand.; Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand.
Nesdale A; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
Dobinson HC; Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
Campbell-Stokes P; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
Daniells K; Institute of Environmental Science and Research, Wellington, New Zealand.
Geoghegan J; Institute of Environmental Science and Research, Wellington, New Zealand.; University of Otago, Dunedin, New Zealand.
de Ligt J; Institute of Environmental Science and Research, Wellington, New Zealand.
Jelley L; Institute of Environmental Science and Research, Wellington, New Zealand.; University of Otago, Dunedin, New Zealand.
Seeds R; Institute of Environmental Science and Research, Wellington, New Zealand.
Jennings T; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
Rensburg M; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
Cueto J; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
Caballero E; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
John J; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
Penghulan E; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
Tan CE; Institute of Environmental Science and Research, Wellington, New Zealand.
Ren X; Institute of Environmental Science and Research, Wellington, New Zealand.
Berquist K; Institute of Environmental Science and Research, Wellington, New Zealand.
O'Neill M; Institute of Environmental Science and Research, Wellington, New Zealand.
Marull M; Institute of Environmental Science and Research, Wellington, New Zealand.
Yu C; Institute of Environmental Science and Research, Wellington, New Zealand.
McNeill A; Institute of Environmental Science and Research, Wellington, New Zealand.
Kiedrzynski T; Te Pou Hauora Tūmatanui, the Public Health Agency, Manatū Hauora, Ministry of Health, Wellington, New Zealand.
Roberts S; Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand.
McArthur C; Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand.
Stanley A; Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand.
Taylor S; Te Whatu Ora, Health New Zealand Counties Manukau, Auckland, New Zealand.
Wong C; Te Whatu Ora, Health New Zealand Counties Manukau, Auckland, New Zealand.
Lawrence S; Te Whatu Ora, Health New Zealand Counties Manukau, Auckland, New Zealand.
Baker MG; University of Otago, Dunedin, New Zealand.
Kvalsvig A; University of Otago, Dunedin, New Zealand.
Van Der Werff K; Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
McAuliffe G; Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand.
Antoszewska H; Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand.
Dilcher M; Te Whatu Ora, Health New Zealand Waitaha Canterbury, Christchurch, New Zealand.
Fahey J; Te Whatu Ora, Health New Zealand Waitaha Canterbury, Christchurch, New Zealand.
Werno A; Te Whatu Ora, Health New Zealand Waitaha Canterbury, Christchurch, New Zealand.
Elvy J; Southern Community Laboratories, Dunedin, New Zealand.
Grant J; Southern Community Laboratories, Dunedin, New Zealand.
Addidle M; Te Whatu Ora, Health New Zealand Hauora a Toi Bay of Plenty, Tauranga, New Zealand.
Zacchi N; Te Whatu Ora, Health New Zealand Hauora a Toi Bay of Plenty, Tauranga, New Zealand.
Mansell C; Te Whatu Ora, Health New Zealand Waikato, Hamilton, New Zealand.
Widdowson MA; Institute of Tropical Medicine, Antwerp, Belgium.
Thomas PG; WHO Collaborating Centre, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Webby RJ; WHO Collaborating Centre, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Pokaż więcej
Corporate Authors:
BorderRestrictionImpactOnFluRSV Consortium; Institute of Environmental Science and Research, Wellington, New Zealand.; Te Whatu Ora, Health New Zealand Counties Manukau, Auckland, New Zealand.; Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand.; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.; Te Whatu Ora, Health New Zealand Waitaha Canterbury, Christchurch, New Zealand.
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Feb; Vol. 18 (2), pp. e13247.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
COVID-19*/epidemiology
COVID-19*/prevention & control
Respiratory Tract Infections*/epidemiology
Respiratory Tract Infections*/prevention & control
Respiratory Syncytial Virus Infections*/epidemiology
Virus Diseases*
Respiratory Syncytial Virus, Human*
Humans ; New Zealand/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Seroprevalence of Avian Influenza A(H5N6) Virus Infection, Guangdong Province, China, 2022.
Autorzy:
Wang Y
Yang C
Liu Y
Zhang J
Qu W
Liang J
Tu C
Mai Q
Mai K
Feng P
Huang W
Lin Z
Hon C
Yang Z
Pan W
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2024 Apr; Vol. 30 (4), pp. 826-828.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza in Birds*/epidemiology
Influenza, Human*/epidemiology
Animals ; Humans ; Seroepidemiologic Studies ; China/epidemiology ; Birds
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Scalable gradients enable Hamiltonian Monte Carlo sampling for phylodynamic inference under episodic birth-death-sampling models.
Autorzy:
Shao Y; Department of Biostatistics, University of California, Los Angeles, California, United States of America.
Magee AF; Department of Biomathematics, University of California, Los Angeles, California, United States of America.
Vasylyeva TI; Department of Medicine, University of California San Diego, La Jolla, California, United States of America.; Department of Population Health and Disease Prevention, University of California Irvine, Irvine, California, United States of America.
Suchard MA; Department of Biostatistics, University of California, Los Angeles, California, United States of America.; Department of Biomathematics, University of California, Los Angeles, California, United States of America.; Department of Human Genetics, Universtiy of California, Los Angeles, California, United States of America.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2024 Mar 29; Vol. 20 (3), pp. e1011640. Date of Electronic Publication: 2024 Mar 29 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Epidemics*
Hemorrhagic Fever, Ebola*/epidemiology
Humans ; Influenza A Virus, H3N2 Subtype ; Algorithms ; Monte Carlo Method
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024.
Autorzy:
Link-Gelles R
Rowley EAK
DeSilva MB
Dascomb K
Irving SA
Klein NP
Grannis SJ
Ong TC
Weber ZA
Fleming-Dutra KE
McEvoy CE
Akinsete O
Bride D
Sheffield T
Naleway AL
Zerbo O
Fireman B
Hansen J
Goddard K
Dixon BE
Rogerson C
Fadel WF
Duszynski T
Rao S
Barron MA
Reese SE
Ball SW
Dunne MM
Natarajan K
Okwuazi E
Shah AB
Wiegand R
Tenforde MW
Payne AB
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2024 Mar 28; Vol. 73 (12), pp. 271-276. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza Vaccines*
COVID-19*/epidemiology
COVID-19*/prevention & control
Adult ; United States/epidemiology ; Humans ; Adolescent ; COVID-19 Vaccines ; Vaccination ; Hospitalization
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
SARS-CoV-2, influenza A/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022/23 winter season in the UK: a longitudinal surveillance cohort.
Autorzy:
Dietz E; Nuffield Department of Medicine, University of Oxford, Oxford, UK. .; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK. .
Pritchard E; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.
Pouwels K; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Ehsaan M; Berkshire and Surrey Pathology Services, Camberley, UK.
Blake J; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
Gaughan C; Office for National Statistics, Newport, UK.
Haduli E; Berkshire and Surrey Pathology Services, Camberley, UK.
Boothe H; Berkshire and Surrey Pathology Services, Camberley, UK.
Vihta KD; Department of Engineering, University of Oxford, Oxford, UK.
Peto T; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
Stoesser N; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
Matthews P; The Francis Crick Institute, 1 Midland Road, London, UK.; Division of Infection and Immunity, University College London, London, UK.
Taylor N; Office for National Statistics, Newport, UK.
Diamond I; Office for National Statistics, Newport, UK.
Studley R; Office for National Statistics, Newport, UK.
Rourke E; Office for National Statistics, Newport, UK.
Birrell P; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.; UK Health Security Agency, London, UK.
De Angelis D; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
Fowler T; UK Health Security Agency, London, UK.; William Harvey Research Institute, Queen Mary University of London, London, UK.
Watson C; UK Health Security Agency, London, UK.
Eyre D; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.; Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
House T; University of Manchester, Manchester, UK.
Walker AS; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.; The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Mar 26; Vol. 22 (1), pp. 143. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
COVID-19*
Virus Diseases*
Respiratory Syncytial Virus Infections*/epidemiology
Middle Aged ; Humans ; SARS-CoV-2 ; Seasons ; Self Report ; Respiratory Syncytial Viruses ; United Kingdom
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 10250

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies